47 results
425
CRVO
CervoMed Inc
3 Aug 23
Business combination disclosure
4:15pm
/information statement under the heading “Director Independence”:
Diffusion’s board of directors undertook a review of the independence of the proposed
8-K
acj9 vhhyc7
3 Aug 23
Other Events
4:15pm
8-K
EX-10.1
hsxl2gi4xn5yob8
16 Dec 22
Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities
5:10pm
PRRN14A
x6tspikw
6 Dec 22
Revised preliminary proxy statement filed by non-management
8:30am
DEFC14A
zp9lshkn 32q099dz5y
5 Dec 22
Proxy in contested solicitation
5:12pm
PRRN14A
myiwg2zl60v
2 Dec 22
Revised preliminary proxy statement filed by non-management
2:36pm
PRER14A
sr3om2l1r0ep
28 Nov 22
Preliminary revised proxy
5:17pm
PREC14A
vu35cx 8x0
23 Nov 22
Preliminary proxy with contested solicitation
11:26am
PREC14A
p5tr94binl8 m1m0
18 Nov 22
Preliminary proxy with contested solicitation
5:08pm
8-K
EX-1.1
oiw00ntm 137v4gos
22 Jul 22
Entry into a Material Definitive Agreement
4:20pm
8-K
EX-1.1
f2y5 ahen6pud6umi
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm